Since then, brain-type transferrin was proposed to be diagnostic for many neurological diseases such as Alzheimer’s disease, vanishing white matter disease, or spontaneous intracranial hypotension [7,8,24,25,26]. Here, TF is linked to early-onset autosomal dominant Alzheimer disease.